Lemonaid Health vs Willow

Both sell tirzepatide. Lemonaid Health costs $348 a month and Willow costs $399, a difference of $51 a month or about $612 a year. The desk reads it as follows.

Lemonaid Health is established platform with multi-month discounts. Willow is straightforward single-price plans. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Lemonaid Health advertises $229 and bills $348; Willow advertises $399 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

On every attribute we track these two behave identically — same answer on dose pricing, commitment, pharmacy disclosure, formats, insurance and what the price includes. When that happens the decision really is just the monthly figure, and Lemonaid Health is $51 a month cheaper.

What each puts on the record: Lemonaid Health

• GLP-1 programmes advertised from $129/month.
• Membership is $49/month after the first month.
• Compounded tirzepatide: $299/month monthly, $249/month on a 3-month plan, $229/month on a 6-month plan.
• A compounded tirzepatide microdose tier is listed at $199/month.
• Medication is billed separately from the membership.

Where it wins: Multi-month plans cut the medication price substantially. Watch for: Add $49/month to every price you are quoted. The advertised $129 is a programme floor, not the injection cost.

What each puts on the record: Willow

• Compounded tirzepatide listed at $399/month.

Where it wins: A single price with no membership arithmetic. Watch for: There is little published detail on how dose changes are handled. Ask before committing.

In each one’s favour

Lemonaid Health.

• Multi-month plans cut the medication price substantially.
• An established platform with a long operating history in telehealth.

Willow.

• A single price with no membership arithmetic.

How they score

Lemonaid Health scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Lemonaid Health if cost is the binding constraint. Over a year the gap is about $612, which is real money for the same class of medication.
• Pick Willow if what it does better matters to you — a single price with no membership arithmetic.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, Lemonaid Health at $348 a month is the more defensible choice on arithmetic alone. Willow earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Lemonaid Health and Willow.

How they sit against everyone else